Health Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Alzheimer Disease
Samaritan Alzheimer's Drug Selected for 2008 ''100 Greatest Investigational Drugs'' by R&D Directions Magazine
May 2nd, 2008
Alzheimer's drug Caprospinol (SP-233), from Samaritan Pharmaceuticals, Inc., (OTCBB:SPHC) a biopharmaceutical company committed to commercializing new innovative therapeutic drugs, was cited by R&D Directions' magazine's seventh-annual list of 100 greatest investigational drugs in development by large and small companies throughout the world. According to R&D Directions, compounds on this list distinguish themselves as "innovative, first-in-class or clearly advanced compared with those on the market." Six drugs for Alzheimer's disease, some also targeting other cognitive disorders, were chosen, including candidates from Wyeth...
Source: Health Business Week (2008-05-02)
|
